$TPB

Turning Point Brands, Inc.

No enriched coverage for $TPB in the last 7 days.

No SEC Form 4 filings for $TPB in the last 30 days.

Low

Why This Fund Trimmed $4 Million of Turning Point Brands Despite Surging Oral Nicotine Sales

Crown Advisors Management, Inc. reduced its stake in Turning Point Brands (NYSE:TPB) by 35,000 shares, an estimated $3.90 million trade, in the first quarter of 2026. This divestment occurred despite Turning Point Brands being a diversified consumer products company focused on tobacco and next-generation alternatives with strong market positions. The fund's holding value in TPB decreased by $4.12 million, reflecting both the share sale and underlying price changes.

M&T Bank Corp Increases Stake in Turning Point Brands, Inc. $TPB

M&T Bank Corp significantly increased its stake in Turning Point Brands, Inc. (NYSE:TPB) by 712.5% in the fourth quarter, now owning 19,499 shares valued at approximately $2.11 million. This makes M&T Bank Corp a 0.10% owner of the company, which has an overall institutional ownership of about 96.1%. Despite this, some insider selling occurred, with CFO Andrew Flynn reducing his holding by 17.48% in March.

Why Turning Point Brands Stock Fell 15.5% This Week

Turning Point Brands (TPB) stock fell 15.5% this week due to reports of slower Food and Drug Administration (FDA) approvals for nicotine pouches, a fast-growing segment for the company. The FDA's hesitation stems from concerns over unknown health impacts and use among younger individuals, reminiscent of the vaping epidemic. Despite the company's stock being down significantly from its highs, its diverse revenue streams from rolling papers, chewing tobacco, and nicotine pouches could make it an attractive buy for investors who see the FDA issues as a temporary setback.